{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:10:54Z","timestamp":1787224254184,"version":"build-2736575974"},"reference-count":94,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cytomegalovirus (CMV) is a major determinant of post-transplant morbidity in solid organ transplant recipients, not only through direct viral disease but also through a broad spectrum of indirect effects that may adversely influence graft and patient outcomes. This review summarizes current clinical and mechanistic evidence regarding the mechanisms of CMV-associated indirect injury in transplantation, drawing on human observational studies together with supporting in vitro and animal-model data. CMV establishes lifelong latency with intermittent reactivation and exerts sustained immunomodulatory effects on both innate and adaptive immunity, which may persist even during low-level viral replication. The mechanisms discussed include monocyte reprogramming, altered antigen presentation, T-cell and natural killer cell dysregulation, endothelial activation and dysfunction, chronic inflammatory signaling, impaired antimicrobial defense, and disturbances in metabolic regulation. The review considers how these mechanisms have been proposed to translate into major post-transplant complications, including acute rejection, chronic allograft dysfunction, cardiovascular and thrombotic disease, post-transplant diabetes, and increased susceptibility to secondary bacterial, fungal, and viral infections. It also addresses current preventive strategies, although evidence regarding their effectiveness in reducing indirect clinical outcomes remains limited and largely observational. Much of the supporting evidence is associative, and the contribution of CMV is often difficult to separate from that of the overall immunosuppressive burden and the comorbidities of transplant recipients. With these considerations, the available evidence supports regarding CMV not merely as an opportunistic pathogen, but as a persistent immunobiological driver of long-term transplant injury. Improved understanding of these indirect effects may enhance risk stratification, support biomarker-guided prevention, and inform future strategies aimed at reducing long-term graft dysfunction and patient morbidity after transplantation.<\/jats:p>","DOI":"10.3390\/jcm15124671","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:27:21Z","timestamp":1781666841000},"page":"4671","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanisms of the Indirect Effects of CMV Infection in Solid Organ Transplant Recipients: A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4214-3882","authenticated-orcid":false,"given":"Anna","family":"Podraza","sequence":"first","affiliation":[{"name":"Department of Immunology, Transplantology, Nephrology and Internal Diseases, Warsaw Medical University, Nowogrodzka Str. 59, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7282-0177","authenticated-orcid":false,"given":"Dominika","family":"D\u0119borska-Materkowska","sequence":"additional","affiliation":[{"name":"Department of Immunology, Transplantology, Nephrology and Internal Diseases, Warsaw Medical University, Nowogrodzka Str. 59, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2400-9328","authenticated-orcid":false,"given":"Dorota","family":"Kami\u0144ska","sequence":"additional","affiliation":[{"name":"Clinical Trials Support Centre, 4th Military Clinical Hospital, 50-981 Wroc\u0142aw, Poland"},{"name":"Division of Nephrology, Transplantology and Clinical Immunology, 4th Military Clinical Hospital, Faculty of Medicine, Wroclaw University of Science and Technology, 50-370 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-7638","authenticated-orcid":false,"given":"Krzysztof","family":"Mucha","sequence":"additional","affiliation":[{"name":"Department of Immunology, Transplantology, Nephrology and Internal Diseases, Warsaw Medical University, Nowogrodzka Str. 59, 02-006 Warsaw, Poland"},{"name":"Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Keyvanfar, A., Tehrani, S., Falah Tafti, M., Talebian, N., Mohammadi, Z., Hojabri, M., Ramezani, S., Yasaei, M., Khorrami, S., and Nezami, S. (2025). Cytomegalovirus infection contributes to acute rejection in solid organ transplant recipients: A systematic review and meta-analysis. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-11648-1"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Dobrer, S., Sherwood, K.R., Davis, K., Lan, J.H., Gill, J., Matic, N., and Keown, P.A. (2025). Impact of viral load kinetics and recurrent cytomegalovirus infection in kidney transplantation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1600289"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.transproceed.2011.05.007","article-title":"Influence of cytomegalovirus disease in outcome of solid organ transplant patients","volume":"43","author":"Linares","year":"2011","journal-title":"Transpl. Proc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e13512","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin. Transpl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"eaax9856","DOI":"10.1126\/sciadv.aax9856","article-title":"Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function","volume":"6","author":"Sen","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.cmi.2022.05.034","article-title":"Comparative clinical manifestations and immune effects of cytomegalovirus infections following distinct types of immunosuppression","volume":"28","author":"Ong","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40121-022-00746-1","article-title":"New Insights on CMV Management in Solid Organ Transplant Patients: Prevention, Treatment, and Management of Resistant\/Refractory Disease","volume":"12","author":"Kotton","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2009.02824.x","article-title":"The \u2018indirect\u2019 effects of cytomegalovirus infection","volume":"9","author":"Freeman","year":"2009","journal-title":"Am. J. Transpl."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1086\/527397","article-title":"Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: Late-onset disease and indirect consequences","volume":"46","author":"Legendre","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"12732","DOI":"10.1111\/tid.12732","article-title":"Burden of cytomegalovirus disease in solid organ transplant recipients: A national matched cohort study in an inpatient setting","volume":"19","author":"Hakimi","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41423-024-01186-2","article-title":"Immune surveillance of cytomegalovirus in tissues","volume":"21","author":"Mihalic","year":"2024","journal-title":"Cell Mol. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41577-019-0225-5","article-title":"Modulation of innate and adaptive immunity by cytomegaloviruses","volume":"20","author":"Berry","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e70063","DOI":"10.1002\/rmv.70063","article-title":"Cell Biology of Human Cytomegalovirus Latency: Implications for Pathogenesis and Treatment","volume":"35","author":"Reeves","year":"2025","journal-title":"Rev. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ajt.15183","article-title":"Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis","volume":"19","author":"Leeaphorn","year":"2019","journal-title":"Am. J. Transpl."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/lt.26045","article-title":"Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients","volume":"27","author":"Vutien","year":"2021","journal-title":"Liver Transpl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e14081","DOI":"10.1111\/tid.14081","article-title":"The effect of late-onset CMV infection on the outcome of renal allograft considering initial graft function","volume":"25","author":"Shahmirzadi","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ahn, R., Schaenman, J., Qian, Z., Pickering, H., Groysberg, V., Rossetti, M., Llamas, M., Hoffmann, A., Gjertson, D., and Deng, M. (2021). Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.750659"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ishikawa, S., Tasaki, M., Saito, K., Nakagawa, Y., Ikeda, M., Takahashi, K., and Tomita, Y. (2023). Long-term CMV monitoring and chronic rejection in renal transplant recipients. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1190794"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/ajt.13791","article-title":"The Cell Biology of Cytomegalovirus: Implications for Transplantation","volume":"16","author":"Kaminski","year":"2016","journal-title":"Am. J. Transpl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/ajt.13010","article-title":"Circulating NK-cell subsets in renal allograft recipients with anti-HLA donor-specific antibodies","volume":"15","author":"Crespo","year":"2015","journal-title":"Am. J. Transpl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1097\/TXD.0000000000000750","article-title":"Human Cytomegalovirus Infection Increases Both Antibody- and Non-Antibody-Dependent Cellular Reactivity by Natural Killer Cells","volume":"3","author":"Michelo","year":"2017","journal-title":"Transpl. Direct"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1111\/ajt.17116","article-title":"Murine cytomegalovirus promotes renal allograft inflammation via Th1\/17 cells and IL-17A","volume":"22","author":"Dhital","year":"2022","journal-title":"Am. J. Transpl."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Stranavova, L., Pelak, O., Svaton, M., Hruba, P., Fronkova, E., Slavcev, A., Osickova, K., Maluskova, J., Hubacek, P., and Fronek, J. (2019). Heterologous Cytomegalovirus and Allo-Reactivity by Shared T Cell Receptor Repertoire in Kidney Transplantation. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02549"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Gabor, F., Jahn, G., Sedmak, D.D., and Sinzger, C. (2020). In vivo Downregulation of MHC Class I Molecules by HCMV Occurs During All Phases of Viral Replication but Is Not Always Complete. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00283"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e01901-19","DOI":"10.1128\/JVI.01901-19","article-title":"Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line","volume":"94","author":"Sandhu","year":"2020","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/TP.0000000000004297","article-title":"Infection, Rejection, and the Connection","volume":"107","author":"Higdon","year":"2023","journal-title":"Transplantation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1097\/00007890-200006270-00026","article-title":"Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft","volume":"69","author":"Kloover","year":"2000","journal-title":"Transplantation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.TP.0000148239.00384.F0","article-title":"Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients","volume":"79","author":"Rowshani","year":"2005","journal-title":"Transplantation"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Yang, B., Ye, Q., Huang, C., and Ding, X. (2023). Impact of Infection-Related Immunosuppressant Reduction on Kidney Transplant Outcomes: A Retrospective Study Considering the Temporal Dynamics of Immunosuppressive Requirements. Transpl. Int., 36.","DOI":"10.3389\/ti.2023.11802"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Cristescu, C.V., Alain, S., and Ruta, S.M. (2022). The Role of CMV Infection in Primary Lesions, Development and Clinical Expression of Atherosclerosis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11133832"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100860","DOI":"10.1016\/j.trre.2024.100860","article-title":"Cytomegalovirus infection and cardiovascular outcomes in abdominal organ transplant recipients: A systematic review and meta-analysis","volume":"38","author":"Arvanitis","year":"2024","journal-title":"Transpl. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1043","DOI":"10.1002\/cti2.1043","article-title":"A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population","volume":"8","author":"Lee","year":"2019","journal-title":"Clin. Transl. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.amjmed.2019.06.021","article-title":"Productive Cytomegalovirus Infection Is Associated with Impaired Endothelial Function in ST-Elevation Myocardial Infarction","volume":"133","author":"Lebedeva","year":"2020","journal-title":"Am. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/cid\/ciaa125","article-title":"Donor Graft Cytomegalovirus Serostatus and the Risk of Arterial and Venous Thrombotic Events in Seronegative Recipients After Non-Thoracic Solid Organ Transplantation","volume":"72","author":"Belga","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/abbs\/gmaa005","article-title":"The role of human cytomegalovirus in atherosclerosis: A systematic review","volume":"52","author":"Zhu","year":"2020","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.20411\/pai.v5i1.382","article-title":"Novel Strategies to Combat CMV-Related Cardiovascular Disease","volume":"5","author":"Vasilieva","year":"2020","journal-title":"Pathog. Immun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.CIR.0000109692.16004.AF","article-title":"Cytomegalovirus infection impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine in transplant arteriosclerosis","volume":"109","author":"Weis","year":"2004","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11262-018-1532-9","article-title":"Human cytomegalovirus-encoded miR-UL112 contributes to HCMV-mediated vascular diseases by inducing vascular endothelial cell dysfunction","volume":"54","author":"Shen","year":"2018","journal-title":"Virus Genes"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lunardi, C., Dolcino, M., Peterlana, D., Bason, C., Navone, R., Tamassia, N., Tinazzi, E., Beri, R., Corrocher, R., and Puccetti, A. (2007). Endothelial cells\u2019 activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: Relevance to the pathogenesis of atherosclerosis. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000473"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/vim.2022.0139","article-title":"Human Cytomegalovirus Infection and Cardiovascular Disease: Current Perspectives","volume":"36","author":"Lee","year":"2023","journal-title":"Viral Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00125-002-0852-3","article-title":"The role of viruses in human diabetes","volume":"45","author":"Hyoty","year":"2002","journal-title":"Diabetologia"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2213-8587(15)00387-3","article-title":"Post-transplantation diabetes-state of the art","volume":"4","author":"Sharif","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.7861\/clinmed.2019-0195","article-title":"Post-transplant diabetes mellitus","volume":"19","author":"Chowdhury","year":"2019","journal-title":"Clin. Med."},{"key":"ref_45","first-page":"e949855","article-title":"Risk Factors for Development of Post-Transplant Diabetes Mellitus After Kidney Transplantation and Comparison Between Older and Younger Recipients in the Early Post-Transplantation Period: A Single-Center Study","volume":"30","author":"Gozdowska","year":"2025","journal-title":"Ann. Transpl."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ndt\/gfx281","article-title":"New-onset diabetes after kidney transplantation: Can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?","volume":"33","author":"Santos","year":"2018","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41574-018-0137-7","article-title":"Post-transplant diabetes mellitus in patients with solid organ transplants","volume":"15","author":"Jenssen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1007\/s00125-004-1499-z","article-title":"Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation","volume":"47","author":"Hjelmesaeth","year":"2004","journal-title":"Diabetologia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"14791641221137352","DOI":"10.1177\/14791641221137352","article-title":"Ten-year incidence of post-transplant Diabetes Mellitus in renal transplant patients","volume":"19","author":"Habibnia","year":"2022","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4285\/kjt.20.0026","article-title":"Incidence and relative risk factors in posttransplant diabetes mellitus patients: A retrospective cohort study","volume":"34","author":"Cheng","year":"2020","journal-title":"Korean J. Transpl."},{"key":"ref_51","first-page":"139","article-title":"The impact of cytomegalovirus infection on new-onset diabetes mellitus after kidney transplantation: A review on current findings","volume":"3","author":"Einollahi","year":"2014","journal-title":"J. Nephropathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jdi.13317","article-title":"Risk factors for new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis","volume":"12","author":"Xia","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Rossi, M.R., Mazzali, M., and de Sousa, M.V. (2024). Post-transplant diabetes mellitus: Risk factors and outcomes in a 5-year follow-up. Front. Clin. Diabetes Health, 5.","DOI":"10.3389\/fcdhc.2024.1336896"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1038\/s41598-021-84400-9","article-title":"Analysis of the frequency of single nucleotide polymorphisms in cytokine genes in patients with New Onset Diabetes After Transplant","volume":"11","author":"Jahromi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00592-014-0573-3","article-title":"Prospective study of cytomegalovirus seropositivity and risk of mortality from diabetes","volume":"51","author":"Mendy","year":"2014","journal-title":"Acta Diabetol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1742-4933-9-18","article-title":"Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study","volume":"9","author":"Chen","year":"2012","journal-title":"Immun. Ageing"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Sun, J., Guo, M., and Yuan, X. (2023). Progress of new-onset diabetes after liver and kidney transplantation. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1091843"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ndt\/gfi033","article-title":"Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage","volume":"20","author":"Hjelmesaeth","year":"2005","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MPA.0b013e31821fc90c","article-title":"Susceptibility of human pancreatic beta cells for cytomegalovirus infection and the effects on cellular immunogenicity","volume":"41","author":"Smelt","year":"2012","journal-title":"Pancreas"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1210\/jc.2016-4029","article-title":"A Histological Study of Fulminant Type 1 Diabetes Mellitus Related to Human Cytomegalovirus Reactivation","volume":"102","author":"Yoneda","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"102304","DOI":"10.1016\/j.trim.2025.102304","article-title":"Immunomodulation in post-transplant diabetes mellitus: Challenges and management","volume":"93","author":"Maoz","year":"2025","journal-title":"Transpl. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1262-3636(06)72809-9","article-title":"Immunosuppressive drug-induced diabetes","volume":"32","author":"Penfornis","year":"2006","journal-title":"Diabetes Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1530\/EJE-09-1034","article-title":"Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men","volume":"162","author":"Nofrate","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/ajt.14323","article-title":"Deciphering Tacrolimus-Induced Toxicity in Pancreatic beta Cells","volume":"17","author":"Trinanes","year":"2017","journal-title":"Am. J. Transpl."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e13080","DOI":"10.1111\/tid.13080","article-title":"Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes","volume":"21","author":"Jorgenson","year":"2019","journal-title":"Transpl. Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/QCO.0000000000000888","article-title":"Risk factors and outcome of concurrent and sequential multiviral cytomegalovirus, Epstein-Barr virus, BK virus, adenovirus and other viral reactivations in transplantation","volume":"35","author":"Sim","year":"2022","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/TP.0000000000004871","article-title":"Risk Factors for Early Fungal Disease in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis","volume":"108","author":"Pennington","year":"2024","journal-title":"Transplantation"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1097\/TP.0000000000003576","article-title":"A Comprehensive Evaluation of Risk Factors for Pneumocystis jirovecii Pneumonia in Adult Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis","volume":"105","author":"Permpalung","year":"2021","journal-title":"Transplantation"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Chuleerarux, N., Thongkam, A., Manothummetha, K., Nematollahi, S., Dioverti-Prono, V., Torvorapanit, P., Langsiri, N., Worasilchai, N., Plongla, R., and Chindamporn, A. (2021). Does Post-Transplant Cytomegalovirus Increase the Risk of Invasive Aspergillosis in Solid Organ Transplant Recipients? A Systematic Review and Meta-Analysis. J. Fungi, 7.","DOI":"10.3390\/jof7050327"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Planchon, M.S., Fishman, J.A., and El Khoury, J. (2024). Modulation of Monocyte Effector Functions and Gene Expression by Human Cytomegalovirus Infection. Viruses, 16.","DOI":"10.3390\/v16121809"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/ajt.15371","article-title":"Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients","volume":"19","author":"Ferreira","year":"2019","journal-title":"Am. J. Transpl."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41467-017-02624-8","article-title":"Human cytomegalovirus-encoded US9 targets MAVS and STING signaling to evade type I interferon immune responses","volume":"9","author":"Choi","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"14289","DOI":"10.1128\/JVI.02552-14","article-title":"The human cytomegalovirus UL26 protein antagonizes NF-kappaB activation","volume":"88","author":"Mathers","year":"2014","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Hancock, M.H., Hook, L.M., Mitchell, J., and Nelson, J.A. (2017). Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-kappaB-Activating Factors through Direct Downregulation of IKKalpha and IKKbeta. mBio, 8.","DOI":"10.1128\/mBio.00109-17"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1111\/ajt.13396","article-title":"Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients","volume":"15","author":"Meijers","year":"2015","journal-title":"Am. J. Transpl."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/TP.0000000000002396","article-title":"Clinical Correlation of Cytomegalovirus Infection With CMV-specific CD8+ T-cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients","volume":"103","author":"Meesing","year":"2019","journal-title":"Transplantation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1600-6143.2008.02279.x","article-title":"PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy","volume":"8","author":"Sester","year":"2008","journal-title":"Am. J. Transpl."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Higdon, L.E., Gustafson, C.E., Ji, X., Sahoo, M.K., Pinsky, B.A., Margulies, K.B., Maecker, H.T., Goronzy, J., and Maltzman, J.S. (2021). Association of Premature Immune Aging and Cytomegalovirus After Solid Organ Transplant. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.661551"},{"key":"ref_79","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","volume":"5","author":"Vernooij","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_80","first-page":"CD005133","article-title":"Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients","volume":"1","author":"Vernooij","year":"2025","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s15010-024-02441-4","article-title":"Prophylactic vs preemptive strategy for the prevention of CMV disease in solid organ transplant recipients: Systematic review and meta-analysis of randomized controlled trials","volume":"53","author":"Hoffman","year":"2025","journal-title":"Infection"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1681\/ASN.0000000000000090","article-title":"A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients","volume":"34","author":"Reischig","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/TP.0000000000002024","article-title":"Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial","volume":"102","author":"Witzke","year":"2018","journal-title":"Transplantation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"180115","DOI":"10.1172\/jci.insight.180115","article-title":"Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis","volume":"9","author":"Zamora","year":"2024","journal-title":"JCI Insight"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am. J. Transpl."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in D+\/R\u2212 kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: Two-year results of the IMPACT study","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/jama.2020.3138","article-title":"Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients with Seropositive Donors: A Randomized Clinical Trial","volume":"323","author":"Singh","year":"2020","journal-title":"JAMA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e70219","DOI":"10.1111\/ctr.70219","article-title":"Long-Term Outcomes Among Lung Transplant Recipients with High-Risk Cytomegalovirus Mismatch Managed with a Multimodality Regimen","volume":"39","author":"Banga","year":"2025","journal-title":"Clin. Transpl."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/cid\/ciad575","article-title":"Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial","volume":"78","author":"Manuel","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000001095","article-title":"The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV","volume":"100","author":"Carbone","year":"2016","journal-title":"Transplantation"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Deborska-Materkowska, D., Perkowska-Ptasinska, A., Sadowska, A., Gozdowska, J., Ciszek, M., Serwanska-Swietek, M., Domagala, P., Miszewska-Szyszkowska, D., Sitarek, E., and Jozwik, A. (2018). Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3075-z"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/ajt.15160","article-title":"Impact of MBL2 gene polymorphisms on the risk of infection in solid organ transplant recipients: A systematic review and meta-analysis","volume":"19","author":"Gimenez","year":"2019","journal-title":"Am. J. Transpl."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00005-023-00674-z","article-title":"Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications","volume":"71","author":"Siemaszko","year":"2023","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e2405","DOI":"10.1002\/rmv.2405","article-title":"Indirect effects of cytomegalovirus infection: Implications for vaccine development","volume":"33","author":"Moseley","year":"2023","journal-title":"Rev. Med. Virol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4671\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:23:54Z","timestamp":1782264234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":94,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124671"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124671","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}